A detailed history of Eagle Bay Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 533 shares of CRL stock, worth $99,015. This represents 0.06% of its overall portfolio holdings.

Number of Shares
533
Previous 608 12.34%
Holding current value
$99,015
Previous $125,000 16.8%
% of portfolio
0.06%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$187.96 - $245.29 $14,097 - $18,396
-75 Reduced 12.34%
533 $104,000
Q2 2024

Jul 26, 2024

SELL
$206.39 - $268.73 $8,049 - $10,480
-39 Reduced 6.03%
608 $125,000
Q1 2024

May 08, 2024

SELL
$203.52 - $273.43 $32,156 - $43,201
-158 Reduced 19.63%
647 $175,000
Q4 2023

Feb 08, 2024

SELL
$164.52 - $238.84 $6,580 - $9,553
-40 Reduced 4.73%
805 $190,000
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $34,804 - $38,952
179 Added 26.88%
845 $165,000
Q2 2023

Aug 10, 2023

SELL
$183.71 - $210.25 $20,942 - $23,968
-114 Reduced 14.62%
666 $140,000
Q1 2023

Apr 24, 2023

SELL
$191.89 - $259.92 $10,553 - $14,295
-55 Reduced 6.59%
780 $157,000
Q4 2022

Jan 26, 2023

BUY
$197.11 - $250.07 $108,410 - $137,538
550 Added 192.98%
835 $0
Q3 2022

Nov 22, 2022

SELL
$182.44 - $250.54 $63,489 - $87,187
-348 Reduced 54.98%
285 $57,000
Q2 2022

Aug 19, 2022

BUY
$204.13 - $302.4 $97,574 - $144,547
478 Added 308.39%
633 $135 Million
Q1 2022

May 11, 2022

SELL
$255.51 - $362.11 $40,370 - $57,213
-158 Reduced 50.48%
155 $44,000
Q4 2021

Jan 21, 2022

BUY
$351.38 - $448.68 $16,866 - $21,536
48 Added 18.11%
313 $118,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $30,556 - $37,580
-82 Reduced 23.63%
265 $108,000
Q2 2021

Jul 30, 2021

BUY
$294.17 - $371.65 $102,076 - $128,962
347 New
347 $130,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.